Hansoh Pharmaceutical

Hansoh and Atomwise announced an expansion of their strategic partnership for AI-accelerated drug discovery, after a first hit-discovery collaboration that identified and experimentally confirmed novel hit compounds for a challenging oncology target. The release says the collaboration began in November 2019 and that Atomwise used its AtomNet AI technology to screen a virtual library of over 12 billion compounds, finding 200 predicted candidates with target specificity in two weeks from a single virtual screen.

Partners: Atomwise